Exact Mass: 1052.5290691999999

Exact Mass Matches: 1052.5290691999999

Found 7 metabolites which its exact mass value is equals to given mass value 1052.5290691999999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PIP(22:3(10Z,13Z,16Z)/5-iso PGF2VI)

{[(1S,6R,10Z,13R,14S,16R,17S,18R,19R,20R,21S,22R)-3,14,16,18,20,21,22-heptahydroxy-17-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-3,8-dioxo-6-{[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]methyl}-2,4,7-trioxa-3lambda5-phosphabicyclo[11.6.3]docos-10-en-19-yl]oxy}phosphonic acid

C50H86O19P2 (1052.5238266)


PIP(22:3(10Z,13Z,16Z)/5-iso PGF2VI) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:3(10Z,13Z,16Z)/5-iso PGF2VI), in particular, consists of one chain of 10Z,13Z,16Z-docosenoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(5-iso PGF2VI/22:3(10Z,13Z,16Z))

{[(1S,6R,11Z,14R,15S,17R,18S,19R,20R,21R,22S,23R)-3,15,17,19,21,22,23-heptahydroxy-18-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-3,9-dioxo-6-[(10Z,13Z,16Z)-tricosa-10,13,16-trienoyloxy]-2,4,8-trioxa-3lambda5-phosphabicyclo[12.6.3]tricos-11-en-20-yl]oxy}phosphonic acid

C50H86O19P2 (1052.5238266)


PIP(5-iso PGF2VI/22:3(10Z,13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(5-iso PGF2VI/22:3(10Z,13Z,16Z)), in particular, consists of one chain of 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of 10Z,13Z,16Z-docosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   
   

PIP(22:3(10Z,13Z,16Z)/5-iso PGF2VI)

PIP(22:3(10Z,13Z,16Z)/5-iso PGF2VI)

C50H86O19P2 (1052.5238266)


   

PIP(5-iso PGF2VI/22:3(10Z,13Z,16Z))

PIP(5-iso PGF2VI/22:3(10Z,13Z,16Z))

C50H86O19P2 (1052.5238266)


   

3-[(3s,6s,12s,18s,21s,24s,27s,30s,33s)-21-[(2s)-butan-2-yl]-5,14,17,20,23,26,29,32-octahydroxy-30-[(1r)-1-hydroxyethyl]-12,27-bis(hydroxymethyl)-18-(1h-indol-3-ylmethyl)-3-isopropyl-2,11-dioxo-1,4,10,13,16,19,22,25,28,31-decaazatricyclo[31.3.0.0⁶,¹⁰]hexatriaconta-4,13,16,19,22,25,28,31-octaen-24-yl]propanimidic acid

3-[(3s,6s,12s,18s,21s,24s,27s,30s,33s)-21-[(2s)-butan-2-yl]-5,14,17,20,23,26,29,32-octahydroxy-30-[(1r)-1-hydroxyethyl]-12,27-bis(hydroxymethyl)-18-(1h-indol-3-ylmethyl)-3-isopropyl-2,11-dioxo-1,4,10,13,16,19,22,25,28,31-decaazatricyclo[31.3.0.0⁶,¹⁰]hexatriaconta-4,13,16,19,22,25,28,31-octaen-24-yl]propanimidic acid

C49H72N12O14 (1052.5290691999999)


   

methyl (4s,5r,6s)-4-(2-{[(2r,3r,4s,4ar,6ar,6bs,8as,11r,12r,12as,14ar,14br)-2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicen-4-yl]methoxy}-2-oxoethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

methyl (4s,5r,6s)-4-(2-{[(2r,3r,4s,4ar,6ar,6bs,8as,11r,12r,12as,14ar,14br)-2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicen-4-yl]methoxy}-2-oxoethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C53H80O21 (1052.519183)